Merilyn Varghese, MD MSc (@merilynvarghese) 's Twitter Profile
Merilyn Varghese, MD MSc

@merilynvarghese

Cardiologist @Yale | Fellowship @BIDMC | Former Chief Resident @YaleIM_Chiefs

ID: 1509238155194556416

calendar_today30-03-2022 18:37:09

35 Tweet

174 Followers

219 Following

Cardiology Today (@cardiologytoday) 's Twitter Profile Photo

The number of Medicare beneficiaries participating in cardiac rehabilitation dropped at the onset of the pandemic and had yet to return to pre-pandemic levels as of December 2021 Dhruv Kazi BIDMC Merilyn Varghese, MD MSc #AHA22 #CardioTwitter healio.com/news/cardiolog…

Dhruv Kazi (@kardiologykazi) 's Twitter Profile Photo

Marked declines in #CardiacRehab use since the start of the pandemic. Merilyn Varghese, MD MSc discusses how this may exacerbate disparities in CV outcomes and offers potential solns. 10.15am tomorrow in S104B. Join us! BIDMC Smith Center

George Goshua, MD MSc (@georgegoshuamd) 's Twitter Profile Photo

We can save more lives for our alloimmunized patients medscape.com/viewarticle/98… @medscape 2nd #ASH22 Press Program abstract w/ brilliance from Yale Lab Medicine #RGHauser Chris Tormey #JEHendrickson (now Emory), Harvard Health Policy and Management Ankur Pandya and Satoko Ito, MD PhD (#GoshuaLab). Yale Cancer Center

George Goshua, MD MSc (@georgegoshuamd) 's Twitter Profile Photo

📢💫Satoko Ito, MD PhD = hematologist+palliative care MD+epidemiologist! Her first Yale Cancer Center YaleHematology Yale School of Medicine pub Annals of Int Med in <6 weeks #GoshuaLab Editorial doi.org/10.7326/M22-34… Potent CEA by👏Shuchi Gulati MD: all oral-Xa inhibitors v LMWH in CAT doi.org/10.7326/M22-12…

📢💫<a href="/SatokoItoMDPhD/">Satoko Ito, MD PhD</a> = hematologist+palliative care MD+epidemiologist! Her first <a href="/YaleCancer/">Yale Cancer Center</a> <a href="/YaleHematology/">YaleHematology</a> <a href="/YaleMed/">Yale School of Medicine</a> pub <a href="/AnnalsofIM/">Annals of Int Med</a> in &lt;6 weeks #GoshuaLab
Editorial doi.org/10.7326/M22-34…
Potent CEA by👏<a href="/ShuchiGulati/">Shuchi Gulati MD</a>: all oral-Xa inhibitors v LMWH in CAT doi.org/10.7326/M22-12…
samitshahmd (@samitshahmd) 's Twitter Profile Photo

Now published in American Journal of Cardiology "Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease" Full article: authors.elsevier.com/c/1j5bVgQl0d~5 Led by Pedro Engel, MD, FACC, FSCAI, Veterans Affairs, and our team Yale Cardiology

Now published in <a href="/AmJCardio/">American Journal of Cardiology</a> "Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease" 
Full article: authors.elsevier.com/c/1j5bVgQl0d~5

Led by <a href="/engelpedro/">Pedro Engel, MD, FACC, FSCAI</a>, <a href="/DeptVetAffairs/">Veterans Affairs</a>, and our team <a href="/YaleCardiology/">Yale Cardiology</a>
Dr. Prashant Rao (@drprao) 's Twitter Profile Photo

JAMA Cardiology We profiled exercise BP using plasma proteomics in search of new HTN/CVD biomarkers. TGFBR3 emerged as a novel marker of exercise SBP & incident HTN across multiple cohorts & platforms, supported by genetic/MR experiments Huge team effort 🙏 bit.ly/4cg5krF

<a href="/JAMACardio/">JAMA Cardiology</a> We profiled exercise BP using plasma proteomics in search of new HTN/CVD biomarkers.

TGFBR3 emerged as a novel marker of exercise SBP &amp; incident HTN across multiple cohorts &amp; platforms, supported by genetic/MR experiments

Huge team effort 🙏

bit.ly/4cg5krF
samitshahmd (@samitshahmd) 's Twitter Profile Photo

Now in press in MyJSCAI, our comprehensive review "Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA)" jscai.org/article/S2772-… How should we evaluate women with ischemic heart disease? This our approach Cesia Gallegos, MD MHS FASNC

Now in press in <a href="/MyJSCAI/">MyJSCAI</a>, our comprehensive review "Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA)"

jscai.org/article/S2772-…

How should we evaluate women with ischemic heart disease? This our approach

<a href="/CesiaGallegos/">Cesia Gallegos, MD MHS FASNC</a>